Discover the full record of transactions filed by Huizinga Robert Bindert, Vice-Président Exécutif. Officer active across 1 companies, notably Aurinia Pharmaceuticals Inc.. Aggregated, 11 reports have been published. Total volume traded: €322k. The latest transaction was disclosed on 2 March 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Robert Bindert Huizinga is the Executive Vice President of Research at Aurinia Pharmaceuticals Inc., a biopharmaceutical company. He is responsible for leading research and development initiatives aimed at innovating in the field of medical treatments.